Clinical Pathway Intervention for Pediatric Respiratory Conditions
(SIP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new way to help doctors treat children with asthma, pneumonia, or bronchiolitis in community hospitals. The method uses simple visual guides to ensure doctors follow the best care practices. The goal is to improve health outcomes and reduce hospital stays and costs.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is the Clinical Pathway Intervention for Pediatric Respiratory Conditions safe for children?
The research highlights that children are at a higher risk of adverse drug events (unintended and harmful effects from medications) during treatment, especially in the medication administration stage. Using clinical decision support systems can help reduce these risks and improve safety in pediatric care.12345
How is the Multi-condition Pathway Intervention treatment different from other treatments for pediatric respiratory conditions?
The Multi-condition Pathway Intervention is unique because it uses a standardized clinical pathway approach, which involves a coordinated plan developed by a team of healthcare professionals to improve the quality and efficiency of care for pediatric respiratory conditions. This approach aims to reduce variability in treatment and improve outcomes, such as shorter hospital stays, without increasing readmission rates.678910
What data supports the effectiveness of the treatment Multi-condition Pathway Intervention for pediatric respiratory conditions?
Who Is on the Research Team?
Sunitha Kaiser, MD, MSc
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for children hospitalized with asthma (ages 2-18), pneumonia (ages 2 months to <18 years), or bronchiolitis (<2 years old) in community hospitals. It excludes those with COVID-19, chronic illnesses like lung or heart disease, neurologic disorders, or transfers from other inpatient facilities.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Implementation
Implementation of multi-condition pathway intervention using strategies like audit and feedback, electronic health record integration, and plan-do-study-act cycles
Follow-up
Participants are monitored for adoption of evidence-based practices and secondary outcomes such as hospital readmission and emergency department revisit
What Are the Treatments Tested in This Trial?
Interventions
- Multi-condition Pathway Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Society of Hospital Medicine
Collaborator